Fractyl Health, Inc. Share Price

Fractyl Health, Inc. Share Price

NASDAQ: GUTS | Micro Cap
$0.91
-$0.07 (-7.49%) Last updated on 30 Oct, 2026 | 21:30 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Fractyl Health, Inc. Stock Performance

Open
$0.93
Prev. Close
$0.98
Circuit Range
N/A
Day Range
$0.91 - $0.94
Year Range
$0.38 - $4.73
Volume
1,503
Average Traded
$0.92

Fractyl Health, Inc. Share Price Today

As of 30 October 2026, Fractyl Health, Inc.'s share price is $0.91. The stock opened at $0.93, compared to its previous close of $0.98. During today's trading session, Fractyl Health, Inc.'s share price traded between $0.91 and $0.94, with an average price of $0.92. Over the past 52 weeks, the stock has recorded a high of $4.73 and a low of $0.38. In terms of performance, Fractyl Health, Inc.'s share price has risen by 43.80% over the last six months and is down 26.53% on a year-on-year basis.

Fractyl Health, Inc. Share Price Chart

Line chart of the Fractyl Health, Inc. price trend over the selected period. The price fell overall, ranging from 0.91 to 0.94, ending at 0.91.
$0.91$0.94
L
Show Current Price
H

Fractyl Health, Inc. Stock Fundamentals & Key Indicators

Market Cap
$68.80M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-7.96
Revenue (TTM)
$0.00
Return On Equity (TTM)
6345.35%
Profit Margin
N/A
Debt to Equity
-18.29
Quarterly Earnings Growth YoY
43.99%

Fractyl Health, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$45.60-$43.73$9.22-$25.54
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A4.10%121.08%-377.01%

Fractyl Health, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.09$0.00
Net Profit-$70.43-$140.95
Net Profit Margin-78255.56%N/A
Income ChangeN/A-100.13%

About Fractyl Health, Inc.

Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.

Fractyl Health, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.44
$0.91
+69.65%
Sep 2026
$0.70
$0.54
-27.82%
Aug 2026
$0.69
$0.74
+7.67%
Jul 2026
$0.81
$0.69
-12.64%
Jun 2026
$0.79
$0.79
-1.86%
May 2026
$0.64
$0.81
+27.73%
Apr 2026
$0.45
$0.63
+38.07%
Mar 2026
$0.46
$0.46
-1.72%
Feb 2026
$0.50
$0.47
-0.43%
Jan 2026
$2.25
$0.47
-78.82%
Dec 2025
$1.54
$2.21
+40.89%
Nov 2025
$1.23
$1.56
+26.72%

GUTS Share Price FAQs